ASX 0.26% $82.56 asx limited

biotech dtock >> weekly update

  1. 220 Posts.
    L A T E S T N E W S I N A U S T R A L I A

    MEDIA RELEASE
    Agenix - Blood Clot Detection Trial on Track Brisbane-based biotechnology company Agenix Ltd [ASX:AGX] today announced that the Phase 1a trial of its blood clot imaging agent Thromboview(R) was ...

    MEDIA RELEASE
    Ambri - External Evaluation of SensiDx System Ambri Limited, (ASX:ABI), today announced that it has met its first major milestone for 2003 by placing the SensiDx(TM) System in a large Sydney hos ...

    MEDIA RELEASE
    Austcancer - Collaborates on Cancer Vaccine Trial with Bresagen Ltd Australian Cancer Technology ("AustCancer") (ASX:ACU) has advanced plans for forthcoming Phase 2 clinical trials of its highly promising Pentrix ant ...

    MEDIA RELEASE
    Epitan - First Tanning Drug Trial Volunteer Reports For more information contact: Dr Wayne Millen, Managing Director, EpiTan Limited, Tel: 03 9662 4688 Iain Kirkwood, Chief Administration Officer, Tel ...

    MEDIA RELEASE
    GTG Grants License to University of Utah, Salt Lake Citv, USA. Genetic Technologies Limited (GTG-ASX) is pleased IO mnounce it has granted a research license to its non-coding patents to the Universily of Uta ...

    MEDIA RELEASE
    Imugene - Novel Flea Vaccine Research Achieves Milestone Australian biopharmaceutical group Imugene announced today the successful completion of Stage One of the research and development of a novel flea va ...

    MEDIA RELEASE
    Psivida - Top US Nano-Silicon Expert Collaboration pSivida Limited (ASX:PSD) is pleased to announce that Professor Jeffrey Coffer of the Chemistry Department at Texas Christian University, Fort Worth ...

    SPECIAL FEATURE
    AGT Biosciences Files for Provisional Patent Application for new Genes Australian biotechnology company AGT Biosciences Limited (ASX: AGT) announced today the filing of a provisional patent application in the USA for 5 ne ...

    MEDIA RELEASE
    AMRAD - New Worldwide Licence Agreement with Serono Amrad (ASX-AML) today announced it had granted to Serono (NYSE:SRA, virt-x: SEO), the global biotechnology company, exclusive worldwide rights to deve ...

    SPECIAL FEATURE
    AVT - Signs MOU for Chinese Blood Plasma Project AVT Holdings Limited (AVT) has signed a Memorandum of Understanding with Shenzhen Neptunus Bioengineering Co, Ltd, to sponsor the development of AVT ...

    MEDIA RELEASE
    Genetic Technologies - Acquires New Business to Expand into DNA Testing of Animals Genetic Technologies Limited ("GTG") has previously released to the market details of its priority activities as new information has come to hand. S ...

    MEDIA RELEASE
    IBA Health - Macquarie Bank acquires shares from InHealth Group IBA Health Limited (ASX: IBA), a global supplier of Health IT Solutions, has been advised that Macquarie Bank Limited (ASX: MBL) has entered into an ...

    MEDIA RELEASE
    Novogen Group Commences Phase II Glucan Trial for Skin Ulcer Repair Pharmaceutical company, Novogen Limited, is commencing a Phase II human clinical trial of its novel skin ulcer repair compound, Glucoprime (TM), 'The ...

    MEDIA RELEASE
    ResMed & Guidant announce strategic alliance Collaboration will include co-marketing, research and development, clinical studies, and education in the areas of cardiovascular disease and sleep- ...

    advance and decline

    There were four companies with an increase of of more than 15%: Healthpoint Technologies 36.4%, Epitan 25.9%, Ambri 20.6% and Eastland Medical 18.2%.

    Six companies lost more than 15%: Aquacarotene 29.1%, Premier Bionics 19.4%, Metabolic 17.7%, Prima Biomed 16.7%, Biota 16.1% and Polartechnics 15%.

    keep us posted at
    corporatescreeners.com

 
watchlist Created with Sketch. Add ASX (ASX) to my watchlist
(20min delay)
Last
$82.56
Change
0.210(0.26%)
Mkt cap ! $15.98B
Open High Low Value Volume
$82.15 $82.62 $81.31 $32.75M 400.1K

Buyers (Bids)

No. Vol. Price($)
1 1819 $82.35
 

Sellers (Offers)

Price($) Vol. No.
$82.59 2415 4
View Market Depth
Last trade - 16.10pm 19/02/2020 (20 minute delay) ?
(live)
Last
$82.45
  Change
0.210 ( 0.01 %)
Open High Low Volume
$82.42 $82.61 $81.31 18195
Last updated 15.59pm 19/02/2020 (live) ?
ASX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.